DPT-Hib vaccine

DPT-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis vaccine adsorbed with Hib conjugate vaccine, sometimes abbreviated to DPT-Hib.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.

DPT-Hib vaccine
Combination of
Diphtheria vaccineVaccine
Tetanus vaccineVaccine
Pertussis vaccineVaccine
Hib vaccineVaccine
Clinical data
Trade namesTetramune
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration    		Intramuscular injection
    ATC code

    A branded formulation was marketed in the USA as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth).[2] Tetramune has since been discontinued.[3]

    References
    1. "DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS VACCINE ADSORBED AND HAEMOPHILUS B CONJUGATE VACCINE (Systemic)". Drugs.com. Retrieved 15 July 2018.
    2. "FDA Approval of Use of a New Haemophilus b Conjugate Vaccine and a Combined Diphtheria-Tetanus-Pertussis and Haemophilus b Conjugate Vaccine for Infants and Children". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 23 April 1993. pp. 296–298. Retrieved 15 July 2018.
    3. "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention. Retrieved 15 July 2018.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.